Navigation Links
AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results
Date:3/11/2009

0.48 Net (loss) earnings per share Basic (0.27) (0.26) (1.12) (0.61) 0.64 Diluted (0.27) (0.26) (1.12) (0.61) 0.62 Consolidated Balance Sheet Information (Unaudited) As at December 31, ------------------------------------------------------------------------- (in thousands) 2008 2007 2006 ------------------------------------------------------------------------- ------------------------------------------------------------------------- $ $ $ Cash and cash equivalents 49,226 10,272 8,939 Short-term investments 493 31,115 51,550 Accounts receivable and other current assets 12,005 18,193 41,234 Property, plant and equipment, net 6,682 7,460 13,001 Other long-term assets 39,936 56,323 108,767 ------------------------------------------------------------------------- Total assets 108,342 123,363 223,491 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Accounts payable and other current liabilities 22,121 21,480 15,624 Current portion of long-term debt and payable 49 775 686 Long-term debt and payable 172 - 687 Non-financial long-term liabilities 64,525 12,517 27,615 ------------------------------------------------------------------------- Total liabilities 86,867 34,772 44,612 Shareholders' equity 21,475 88,591 178,879 --
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, ... report to their offering. The global ... CAGR of 22.7% from 2014 to 2019. Factors such ... growing adoption of companion diagnostics by the pharmaceutical industry, ...
(Date:9/18/2014)... -- U.S. biotech company Kultevat has strengthened its ... developed by the Donald Danforth Plant Science Center ... applications in production of natural rubber in Taraxicum ... under the direction of Roger Beachy , Ph.D., ... the Danforth Plant Science Center, and is used to ...
(Date:9/18/2014)... LEXINGTON, Ky. , Sept. 18, 2014  Neogen ... it has entered into a strategic agreement with Merck ... Heifer Program. The Igenity Dairy Heifer ... producers essential information on the genetic potential of replacement ... after a calf is born, and is an excellent ...
(Date:9/18/2014)... septembre 2014 Mapi, société créée à ... a été depuis 40 ans l,un des ... traditionnelles par des évaluations recentrées sur le ... impacts économiques des traitements. Logo ... A cours d,une récente conférence téléphonique avec ...
Breaking Biology Technology:Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3Kultevat obtains license of gene switch technology 2Merck Animal Health to market Neogen's dairy genomic program 21974 - 2014 - Mapi fête ses 40 ans 2
... Claire, Wis. - Anticipating a net loss in 2007, ... announced 165 layoffs at its Eau Claire manufacturing plant, according ... ,Job losses at the Eau Claire plant are part of ... plants in Hutchinson and Plymouth, Minn., and Sioux Falls, S.D. ...
... - The June 30 deadline is approaching ... to $223.9 million in benefits from a class ... to attorneys lawyers involved in the court-approved settlement. ... violated Wisconsin's antitrust and unfair competition laws. , ...
... Abandoned and failed information technology programs have cost state government ... that has some members of the Legislature wondering if it's ... the whole mess. , ,There's probably no need to hit ... cut-and-paste IT operations. Instead, lawmakers should look for best practices ...
Cached Biology Technology:June 30 is deadline to claim up to $223.9M in Microsoft settlement 2Ethics Board site offers welcome contrast to state IT mistakes 2Ethics Board site offers welcome contrast to state IT mistakes 3
(Date:9/21/2014)... of California, San Diego, have developed a program that ... activity of genes based on sequences of DNA. They ... to human embryonic cells in a paper published in ... of our cells have the same blueprint, the same ... lead author of the report. "Skin cells protect, nerve ...
(Date:9/21/2014)... was previously thought, newborn immune T cells may have ... according to a new study led by King,s College ... that of adults, babies may still be able to ... in the journal Nature Medicine . , Our ... of immune cells, including neutrophils which play an important ...
(Date:9/21/2014)... has developed a protein therapy that disrupts the process ... tumor sites, travel through the blood stream and start ... process, known as metastasis, can cause cancer to spread ... who succumb to cancer fall prey to metastatic forms ... of bioengineering who describes a new therapeutic approach in ...
Breaking Biology News(10 mins):Program predicts placement of chemical tags that control gene activity 2Immune system of newborn babies is stronger than previously thought 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4
... (March 7, 2011) -- All our daily activities, from driving ... carried along the body,s vast network of neurons. Propagation of ... within nerve cells -- receptors, ion channels, and transmitters -- ... study of these molecules in real time has not been ...
... up pollution, protecting soil from erosion and maintaining species-rich ecosystems ... by a University of Houston (UH) scientist and his team. ... on a new method to speed up research in the ... computer science and mathematics at UH, and his fellow researchers ...
... Scientists have identified a single mutated gene that causes ... bone loss and osteoporosis (fragile bones). The study, published ... into possible causes of osteoporosis and highlights the gene ... , There are only 50 reported cases of ...
Cached Biology News:Protecting ecosystems, pollution remediation goals of research at UH 2Protecting ecosystems, pollution remediation goals of research at UH 3Gene responsible for severe osteoporosis disorder discovered 2
Request Info...
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
Request Info...
Request Info...
Biology Products: